FRANCISCO JAVIER OLAZARÁN RODRÍGUEZ-rekin lankidetzan egindako argitalpenak (12)

2022

  1. Clinical Trajectories of Neuropsychiatric Symptoms in Mild-Moderate to Advanced Dementia

    Journal of Alzheimer's Disease, Vol. 86, Núm. 2, pp. 861-875

2021

  1. CHROME Criteria and Quality of Life: A Pilot Study from Maria Wolff-Albertia

    Journal of Alzheimer's Disease Reports, Vol. 5, Núm. 1, pp. 613-624

  2. Depression in Alzheimer's Disease: A Delphi Consensus on Etiology, Risk Factors, and Clinical Management

    Frontiers in Psychiatry, Vol. 12

  3. Focus on Depression in Parkinson's Disease: A Delphi Consensus of Experts in Psychiatry, Neurology, and Geriatrics

    Parkinson's Disease, Vol. 2021

  4. Syndrome-Based Prescription to Optimize Psychotropics: Are CHROME Criteria a Game Changer?

    Frontiers in Psychiatry, Vol. 12

2020

  1. Pathological Correlations of Neuropsychiatric Symptoms in Institutionalized People with Dementia

    Journal of Alzheimer's Disease, Vol. 78, Núm. 4, pp. 1731-1741

  2. The CHROME criteria: Tool to optimize and audit prescription quality of psychotropic medications in institutionalized people with dementia

    International Psychogeriatrics, Vol. 32, Núm. 3, pp. 315-324

2019

  1. Effects of commonly prescribed drugs on cognition and mild cognitive impairment in healthy elderly people

    Journal of Psychopharmacology, Vol. 33, Núm. 8, pp. 965-974

2018

  1. Cerebral Microbleeds in Advanced Dementia: Clinical and Pathological Correlates

    American Journal of Alzheimer's Disease and other Dementias, Vol. 33, Núm. 6, pp. 362-372

2017

  1. Structural correlates of apathy in Alzheimer's disease: a multimodal MRI study

    International Journal of Geriatric Psychiatry, Vol. 32, Núm. 8, pp. 922-930

2015

  1. The Vallecas Project: A cohort to identify early markers and mechanisms of Alzheimer's disease

    Frontiers in Aging Neuroscience, Vol. 7, Núm. SEP

2013

  1. Motor effects of REAC in advanced Alzheimer's disease: Results from a pilot trial

    Journal of Alzheimer's Disease, Vol. 36, Núm. 2, pp. 297-302